Walleye Capital LLC Bellus Health Inc. Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$8.22 - $10.76 $884,784 - $1.16 Million
107,638 Added 58.84%
290,565 $2.39 Million
Q3 2022

Nov 14, 2022
BUY
$8.95 - $12.0 $1.64 Million - $2.2 Million
182,927 New
182,927 $1.93 Million
Q1 2022

May 16, 2022
SELL
$5.56 - $7.99 $96,994 - $139,385
-17,445 Closed
0 $0
Q4 2021

Mar 03, 2022
BUY
$5.26 - $8.3 $91,760 - $144,793
17,445 New
17,445 $140,000

Others Institutions Holding BLU

# of Institutions
1
Shares Held
128K
Call Options Held
0
Put Options Held
0
View Full List

About BELLUS Health Inc.

BLU Quotes by TradingView
  • Ticker BLU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,793,000
  • Description
  • BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...
More about BLU
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email